The U.S. FDA opens registration for a public hearing to gather input on the Commissioner’s National Priority Voucher program, a proposed fast review pathway for drugs of national importance.
The FDA is seeking public input on the Commissioner’s National Priority Voucher (CNPV) program—a fast review pathway for drugs of national importance.
Join us June 4 (rescheduled from June 12) for a public hearing:
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new expert voices, debates, and emerging ideas.
← Back to Healthcare